采用奥卡西替尼治疗犬皮肤上皮样 T 细胞淋巴瘤：一例病例报告。

Treatment of canine cutaneous epitheliotropic T-cell lymphoma with oclacitinib: a case report.

机构信息

Dermatology for Animals, 263 Appleby Road, Stafford Heights, QLD, 4053, Australia.

QML Pathology, 11 Riverview Place, Murrarie, QLD, 4172, Australia.

出版信息

Vet Dermatol. 2021 Aug;32(4):398-e113. doi: 10.1111/vde.12976. Epub 2021 May 25.

DOI:10.1111/vde.12976

PMID:34033147

Abstract

Canine cutaneous epitheliotropic T-cell lymphoma (CETL) is associated with a poor prognosis and without consistently beneficial treatment options. This case report describes a 9-year-old Staffordshire bull terrier with CETL treated with oclacitinib (0.7 mg/kg twice daily), resulting in partial remission that was maintained for three months. Further studies are warranted.

摘要

犬皮肤上皮嗜 T 细胞淋巴瘤（CETL）预后不良，且目前尚无有效的治疗方法。本病例报告描述了一例 9 岁的斯塔福郡斗牛梗犬，使用奥卡替尼（0.7mg/kg，每日两次）治疗 CETL，获得部分缓解，缓解期持续三个月。需要进一步的研究。